Company profile

Copan Wasp Srl

Pathology & Laboratory Diagnostics

Company profile

About Copan Wasp Srl

Copan is a global leader in laboratory automation and specimen collection technologies for clinical microbiology. The company's flagship WASP® (Walk-Away Specimen Processor) system automates all facets of microbiology specimen processing, including planting, streaking, Gram slide preparation, broth inoculation, and disk application. With over 1,300 WASP® instruments deployed globally, Copan provides modular, open-platform automation solutions that integrate with any Laboratory Information System (LIS). The company's product portfolio extends beyond automation to include patented FLOQSwabs® flocked fiber technology for superior sample collection, liquid-based microbiology collection systems like ESwab® and FecalSwab®, and advanced AI platforms such as PhenoMATRIX® for intelligent culture interpretation. Copan's WASPLab® offers full laboratory automation with digital microbiology capabilities, while systems like Radian® provide automated disk diffusion setup and interpretation. The company serves clinical laboratories, hospital systems, reference labs, and healthcare facilities worldwide, helping them standardize best practices, minimize operational costs, and improve specimen traceability. Copan's solutions follow Clinical & Laboratory Standards Institute (CLSI) guidelines and the Manual of Clinical Microbiology recommendations. With over 40 years of innovation in sample collection, transport, and preservation systems, Copan collaborates closely with the microbiology community to advance both traditional culture-based and contemporary molecular diagnostic workflows.

Company description Copan Wasp Srl official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Copan Wasp Srl?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • bacteriology
  • enteric bacteria
  • fungal infections
  • general microbiology diagnostics
  • respiratory infections
  • urinary tract infections
  • virology

Who it serves

  • Clinical Laboratories
  • Healthcare Facilities
  • Hospital Systems
  • Reference Labs
  • Research Institutions

Deployment & integration

Embedded · On Premise · Other deployment with recorded integration context.

Recorded integration context: Cerner, Epic, LIS (Laboratory Information Systems).

Geographic context

MarketsGlobal · International markets with 1300+ installations · USA
Company sourceOfficial website

Company milestones

Platform expansion

Over 1,300 WASP® instruments deployed globally. Expansion of AI capabilities with PhenoMATRIX® platform. Development of full laboratory automation suite including WASPLab®, WASP-FLO™, Radian®, and Colibrí™ systems.

Partnerships

Recorded partners

No partners are currently listed.

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Colibrí™

Automated Specimen ID and AST Preparation

Platform · On PremiseCompany source

Collaborative Station

Semi-Manual Specimen Processing

Platform · On PremiseCompany source

ESwab®

Liquid Based Collection and Transport system

Device · OtherCompany source

FecalSwab®

System for Enteric Bacteria collection

Device · OtherCompany source

FLOQSwabs®

Patented flocked swabs for optimal sample collection

Device · OtherCompany source

Gram SlidePrep™ EVO

Automated Gram slide preparation module

Device · EmbeddedCompany source

PhenoMATRIX®

Advanced Artificial Intelligence for Microbiology

Software · EmbeddedCompany source

Radian®

Automated Disk Diffusion Set Up and Interpretation

Platform · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

No linked records are currently available.

Clinical validation

Clinical-trial records

No linked records are currently available.

Regulatory

Regulatory records

PhenoMATRIX

K251511 · 510k · Jan 22, 2026

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

>90% pathogen elution

FLOQSwabs® sample recovery vs traditional swabs

Reduced operational costs

Reusable metal loops vs disposable alternatives

Improved specimen traceability

End-to-end barcode tracking with LIS integration

Standardized best practices

Automated replication of experienced technologist workflows

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Copan Wasp Srl

Recent articles published on Copan Wasp Srl's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon